#T-Bio
Jan. 5th-6th 2023
Shanghai China

Asia Biopharma Innovation and Quality Technology Summit 2023

Buy tickets

Request agenda

Get floorplan

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Biopharma
Enterprises

0 +

Media
Reports

Key words of the conference

Industrial Regulations and Policies, Import Substitution and Local Innovation, Quality By Design, End-To-End Biopharmaceutical Preparation and Application Platform, Domestic Substitution of Processes and Equipment, Cell And Gene Therapy, CAR-T Cell Therapy, Antibody Drugs, Bispecific Antibodies, ADC, Nanobodies, Cell Characterization, Synthetic Biology

Forum Structure

Forum I Antibody Drug Technology and Quality Science	l Experience Sharing of Quality Declaration Requirements for Bispecific Antibody INDs l Design Scale-Up and Intensification Optimization of Modeled Cell Culture Processes and Their Bioreactors l How to Perform Efficient and Rapid Protein Concentration Analysis with Minimal Volume Requirements? l Cell Culture Process Development and Upgrade Guidelines l Anti-CTLA-4 Fully Human Heavy Chain Antibody Preparation Experience and Prospective Flexible Clinical Trial Quality Management System ...

Forum II ADC Drug and Nucleic Acid Drug Process Development and Quality Science	l ADC Quality Process Development and Quality Control Challenges l Key Quality Attributes of ADC Products l How to Build an Intelligent Bioreactor Factory to Meet The Growing Demand for Large-Scale Production? l Concerns in HER2-Targeted ADC Drug Process Development l Development of Key Reagents in Biological Protein Production and Analysis ...

Forum III Cell Therapy Process and Quality Science	l Interpretation of Quality Regulations for Cell Therapy Products l How to Achieve Rapid Sterility Inspection and Rapid Release of Cell Therapy Products? l Allogeneic CAR-T Cell Development and Manufacturing GMP Key Points l Experience Sharing of Preparation and Development of CAR-T Cell Injection Targeting CEA l Commercial Production and Quality Control of CAR-T Cell Therapy Products ...